electroCore Inc (ECOR)
7.225
+0.22
(+3.21%)
USD |
NASDAQ |
May 08, 16:00
7.89
+0.66
(+9.20%)
After-Hours: 20:00
electroCore Enterprise Value: 31.69M for May 7, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 07, 2024 | 31.69M |
May 06, 2024 | 31.69M |
May 03, 2024 | 27.64M |
May 02, 2024 | 26.40M |
May 01, 2024 | 25.92M |
April 30, 2024 | 27.12M |
April 29, 2024 | 23.88M |
April 26, 2024 | 24.24M |
April 25, 2024 | 23.58M |
April 24, 2024 | 23.16M |
April 23, 2024 | 23.64M |
April 22, 2024 | 23.40M |
April 19, 2024 | 23.58M |
April 18, 2024 | 23.52M |
April 17, 2024 | 23.19M |
April 16, 2024 | 22.74M |
April 15, 2024 | 23.70M |
April 12, 2024 | 24.12M |
April 11, 2024 | 25.62M |
April 10, 2024 | 24.66M |
April 09, 2024 | 25.74M |
April 08, 2024 | 24.78M |
April 05, 2024 | 25.80M |
April 04, 2024 | 27.79M |
April 03, 2024 | 27.85M |
Date | Value |
---|---|
April 02, 2024 | 25.02M |
April 01, 2024 | 26.40M |
March 28, 2024 | 26.70M |
March 27, 2024 | 24.90M |
March 26, 2024 | 26.64M |
March 25, 2024 | 26.22M |
March 22, 2024 | 27.25M |
March 21, 2024 | 28.09M |
March 20, 2024 | 27.91M |
March 19, 2024 | 31.27M |
March 18, 2024 | 31.69M |
March 15, 2024 | 29.53M |
March 14, 2024 | 26.22M |
March 13, 2024 | 28.39M |
March 12, 2024 | 26.95M |
March 11, 2024 | 29.35M |
March 08, 2024 | 30.55M |
March 07, 2024 | 30.55M |
March 06, 2024 | 29.65M |
March 05, 2024 | 29.47M |
March 04, 2024 | 30.19M |
March 01, 2024 | 30.19M |
February 29, 2024 | 31.27M |
February 28, 2024 | 31.19M |
February 27, 2024 | 29.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.47M
Minimum
Mar 18 2020
130.49M
Maximum
May 09 2019
26.29M
Average
19.46M
Median
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 1.072B |
Retractable Technologies Inc | -12.89M |
Xtant Medical Holdings Inc | 122.38M |
Asensus Surgical Inc | 46.93M |
Catheter Precision Inc | 0.8298M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -4.032M |
Revenue (Quarterly) | 5.191M |
Total Expenses (Quarterly) | 9.149M |
EPS Diluted (Quarterly) | -0.55 |
Gross Profit Margin (Quarterly) | 78.81% |
Profit Margin (Quarterly) | -77.67% |
Earnings Yield | -48.44% |
Normalized Earnings Yield | -48.44 |